TIGA: Target illumination GWAS analytics
Jeremy J. YangiD, Dhouha GrissaiD, Christophe Gerard LambertiD, Cristian BologaiD, Stephen L. MathiasiD, Anna WalleriD, David J. WildiD, Lars Juhl JenseniD, Tudor Ionel OpreaiD
Abstract
Genome wide association studies (GWAS) can reveal important genotype-phenotype associations, however, data quality and interpretability issues must be addressed. For drug discovery scientists seeking to prioritize targets based on the available evidence, these issues go beyond the single study. Here, we describe rational ranking, filtering and interpretation of inferred gene-trait associations and data aggregation across studies by leveraging existing curation and harmonization efforts. Each gene-trait association is evaluated for confidence, with scores derived solely from aggregated statistics, linking a protein-coding gene and phenotype. We propose a method for assessing confidence in gene-trait associations from evidence aggregated across studies, including a bibliometric assessment of scientific consensus based on the iCite Relative Citation Ratio, and meanRank scores, to aggregate multivariate evidence. This method, intended for drug target hypothesis generation, scoring and ranking, has been implemented as an analytical pipeline, available as open source, with public datasets of results, and a web application designed for usability by drug discovery scientists, at https://unmtid-shinyapps.net/tiga/.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 17
- FWCI
- 1.27
- Field percentile
- top 22%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Benchmarking genome-wide association study causal gene prioritization for drug discovery
Caleb Ji, Isabel Kerrebijn, … Michael Wainberg·medRxiv·Sep 23, 2025
- Integration of genetic evidence to identify approved drug targets
Samuel Moix, Marie C. Sadler, Zoltán Kutalik·Genome MedicinePeer-reviewed·Jul 6, 2026
- TRACE: A FINE-TUNED BIOMEDICAL LANGUAGE MODEL FOR DIRECTIONALLY INFORMED DRUG REPURPOSING FROM TRANSCRIPTOME-WIDE ASSOCIATION STUDIES
Christopher O. Otieno, Hannah M. Seagle, … Todd L. Edwards·medRxiv·Aug 28, 2026
- DISEASES 2.0: a weekly updated database of disease-gene associations from text mining and data integration
Dhouha Grissa, Alexander Junge, … Lars Juhl Jensen·DatabasePeer-reviewed·Jan 1, 2022
- Multi-layered genetic approaches to identify approved drug targets
Marie C. Sadler, Chiara Auwerx, … Zoltán Kutalik·Cell GenomicsPeer-reviewed·Jun 16, 2023
- Scaling genetic discovery through automated post-GWAS interpretation